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Abstract 
Introduction and objectives. 
The present article reports the characteristics and results of heart transplants in Spain since this therapeutic 
modality was first used in May 1984. 
Methods 
We describe the main features of recipients, donors, surgical procedures, and results of all heart transplants 
performed in Spain until December 31, 2015. 
Results 
A total of 299 cardiac transplants were performed in 2015, with the whole series comprising 7588 procedures. 
The main transplant features in 2015 were similar to those observed in recent years. A remarkably high 
percentage of transplants were performed under emergency conditions and there was widespread use of 
circulatory assist devices, particularly continuous-flow left ventricular assist devices prior to transplant (16% 
of all transplants). Survival has significantly improved in the last decade compared with previous time 
periods. 
Conclusions 
During the last few years, between 250 and 300 heart transplants have consistently been performed each year 
in Spain. Despite a more complex clinical context, survival has increased in recent years. 
  
Resumen 
Introducción y objetivos. 
Se presentan las características y los resultados del trasplante cardiaco en España desde que empezó su 
actividad en mayo de 1984. 
Métodos. 
Se realiza un análisis descriptivo de las características de los receptores, los donantes, los procedimientos 
quirúrgicos y los resultados de los trasplantes cardiacos realizados en España hasta el 31 de diciembre de 
2015. 
Resultados. 
Durante 2015 se han realizado 299 procedimientos, con lo que la serie histórica consta de 7.588 trasplantes. 
Las características generales del procedimiento son similares a las observadas en los últimos años y destacan 
el alto porcentaje de procedimientos realizados en código urgente y, sobre todo, la extensión del uso de 
dispositivos de asistencia circulatoria, particularmente la asistencia ventricular de flujo continuo (el 16% del 
total de trasplantes). La supervivencia ha aumentado significativamente en la última década con respecto a 
periodos anteriores. 
Conclusiones. 
La actividad de trasplante cardiaco en España permanece estable en los últimos años, con alrededor de 250-
300 procedimientos al año. A pesar de la mayor complejidad del contexto clínico, se observa una mejora de la 
supervivencia en los últimos años. 
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Since 1991, the Spanish Heart Transplantation Registry (Registro Español de Trasplante 
Cardiaco [RETC]) has published an annual description of the clinical and surgical characteristics 
and general results of all heart transplant procedures performed in Spain 
1-26
. The current article 
reports data on the transplant population until 31 December 2015. As is already well-known, the 
main strength of the RETC lies in its inclusion and comprehensive updating of all heart transplant 
procedures performed in all Spanish hospitals since May 1984, regardless of the procedural 
characteristics and results. In addition, data collection is prospectively performed using a shared 
database developed and updated by all transplant teams. 
METHODS 
Patients and Centers 
Of the 19 centers that have contributed data to the RETC, 18 are currently active (Table 1). 
Two centers are entirely dedicated to pediatric transplantation while another 3 perform both 
pediatric and adult transplantation. The numbers of procedures performed annually are 
summarized in Figure 1. The whole series comprises 7588 procedures. Data were lost on 12 
patients, including follow-up information. These patients have been omitted from the analysis, 
giving a final sample size of 7576 patients. Of the 299 procedures performed in 2015, 22 (7.4%) 
were performed in pediatric patients (age < 16 years). The types of procedures performed in 2015 
and in the whole series are summarized in Table 2. 
Table 1. Centers (by Order of First Transplantation Performed) Participating in 
the Spanish Heart Transplantation Registry (1984-2015) 
 
1. Hospital de la Santa Creu i Sant Pau, Barcelona 
2. Clínica Universitaria de Navarra, Pamplona 
3. Clínica Puerta de Hierro, Majadahonda, Madrid 
4. Hospital Marqués de Valdecilla, Santander 
5. Hospital Reina Sofía, Córdoba (adult and pediatric) 
6. Hospital Universitario y Politécnico La Fe, Valencia 
7. Hospital Gregorio Marañón, Madrid (adult and pediatric) 
8. Fundación Jiménez Díaz, Madrid (1989-1994) 
9. Hospital Virgen del Rocío, Seville 
10. Hospital 12 de Octubre, Madrid 
11. Hospital Universitario de A Coruña, A Coruña (adult and pediatric) 
12. Hospital de Bellvitge, L’Hospitalet de Llobregat, Barcelona 
13. Hospital La Paz, Madrid (pediatric) 
14. Hospital Central de Asturias, Oviedo 
15. Hospital Clínic, Barcelona 
16. Hospital Virgen de la Arrixaca, El Palmar, Murcia 
17. Hospital Miguel Servet, Zaragoza 
18. Hospital Clínico, Valladolid 







Figure 1. Annual number of transplants (1984-2015), total and by age group. 
Table 2. Spanish Heart Transplantation Registry (1984-2015). Type of 
Procedure 
Procedure 2015 1984-2015 
   
De novo heart transplants 292 7243 
Retransplants 4 183 
 Combined retransplants 0 6a 
Combined transplants 3 150 
 Heart-lung 2 74 
 Heart-kidney 1 67b 
 Heart-liver — 9 
Total 299 7576 
   
 
a All renal transplant recipients. 
b Includes heart retransplant recipients. 
Procedures 
The database comprises 175 clinical variables, established by consensus among all the teams, 
and records data on recipients, donors, surgical techniques, immunosuppression, and follow-up. 
Since 2013, the data have been electronically introduced and updated in real time using a web-
based program specifically designed for this purpose. The database support is a Microsoft Excel 
file. This procedure replaces the previous method, in which each center sent data to the registry 
director in Microsoft Access file format via email. An external CRO (contract research 
organization), currently ODDS S.L., performed database maintenance, quality control, and 
statistical analysis.  
Ethics committee approval, auditing, and registration with the Ministry of Health were 
performed in accordance with the Spanish Organic Law on Data Protection 15/1999. 
Statistics 
Continuous quantitative variables are presented as mean ± standard deviation; categorical 
variables are presented as percentages. The results are categorized according to the year of 
transplantation and the total sample has been divided into 4 time periods (1984-1993, 1994-2003, 
2004-2013, and 2014-2015). Some variables were also analyzed according to the annual data from 
the whole series, such as donor age, emergency transplants, and ischemia time. Differences among 
groups were analyzed using a nonparametric test for temporal trends (Kendall τ) for categorical 
variables and analysis of variance test with polynomial fit for continuous variables. Survival 
curves were calculated using the Kaplan-Meier test and were compared using a log rank test. A P 
value < .05 was considered statistically significant. 
RESULTS 
Recipient Characteristics 
In 2015, the recipients had a mean age of 49.5 ± 16.5 years (range, 0.14-73 years); 76% were 
men, with the following underlying diagnoses: ischemic cardiomyopathy (21.4%), nonischemic 
dilated cardiomyopathy (30.4%), valvular heart disease (4.0%), and other etiologies (44.2%). 
Recipient characteristics by transplant period are summarized in Table 3. There were significant 
trends toward older recipients, female sex, atypical causes of underlying heart disease, and an 
increase in pretransplant conditions with known prognostic effects, such as insulin-dependent 
diabetes mellitus, infection, cardiac surgery, and mechanical ventilation prior to transplant. 
Although the difference was not statistically significant, the proportion of retransplants fell below 
2% in 2014-2015, comprising 2.4% of the total series. In contrast, there was a significant decrease 
in pretransplant values of pulmonary vascular resistance and an almost significant decrease in 
pretransplant severe renal dysfunction throughout the time series. 
  
Table 3. Recipient Characteristics in the Spanish Heart Transplantation Registry (1984-2015) 
 
1984-1993 
(n = 1230) 
1994-2003 
(n = 3148) 
2004-2013 
(n = 2633) 
2014-2015 
(n = 565) 
P 
(trend) 
2015 (n = 299) 
       
Age, y 46.7 ± 13.4 50.4 ± 14.6 49.5 ± 16.5 49.7 ± 16.1 < .001 49.5 ± 16.5 
 < 16 y 3.9 4.8 6.8 6.0 < .001 7.4 
 > 60 y 10.0 24.3 27.3 27.6 < .001 27.1 
Men 85.8 81.1 76.1 75.8 < .001 76.3 
BMI 24.2 ± 4.0 25 ± 4.5 24.9 ± 4.7 24.7 ± 4.4 < .001 24.6 ± 4.4 
Underlying etiology 
    
< .001 
 
 Nonischemic dilated 40.8 37.8 37.5 37.9 
 
36.8 
 Ischemic 40.2 43.7 36.5 38.1 
 
39.5 
 Valvular 10.4 7.6 7.8 4.1 
 
3.7 
 Other 8.6 10.8 18.1 20.0 
 
20.1 
PVR (WU) 2.6 ± 1.8 2.3 ± 1.8 2.4 ± 2.2 2.2 ± 1.3 < .001 2.2 ± 1.4 
Creatinine > 2 mg/dL 7.0 6.1 8.3 5.8 .058 5.7 
Bilirubin > 2 mg/dL 19.7 17.8 18.2 16.4 .436 16.0 
Insulin-dependent diabetes 8.5 12.9 17.0 23.9 < .001 26.2 
Moderate-severe COPD 9.3 11.2 9.4 12.2 .044 10.9 
Previous infection 4.0 9.4 13.7 12.7 < .001 11.5 
Previous cardiac surgery 25.3 26.5 28.9 33.8 .001 37.1 
Heart retransplant 2.8 2.1 2.6 1.8 .84 1.3 
Mechanical ventilation 
prior to transplant 
8.3 10.3 16.2 13.8 < .001 15.7 
Emergency transplant 18.1 23.6 34.6 44.4 < .001 47.2 
       
 
BMI, body mass index; COPD, chronic obstructive pulmonary disease; PVR, pulmonary vascular resistance. 
The values in the Underlying etiology section were obtained from previous reports due to updating of the database and 
recoding of the various categories. Values expressed are percentages or mean ± standard deviation. 
Compared with 2014, there was a slight uptick in 2015 in emergency transplants, reaching 
almost half of all procedures. Thus, the use of emergency transplants has remained above 40% 
since 2013 (Figure 2). In 2015, there was another increase in the use of ventricular assist devices 
prior to transplantation, whose use was first recorded in 2009 (P < .001) (Figure 3). Moreover, 
there was increased use of continuous-flow left ventricular assist devices (33.9%) and reduction of 









Figure 3. Distribution of the type of pretransplant circulatory support by time period (1984-2015). ECMO, extracorporeal 






Figure 4. Distribution of the type of pretransplant circulatory support by year (2009-2015). ECMO, extracorporeal 
membrane oxygenation; VAD, ventricular assist device. 
Donor Characteristics and Ischemia Time 
The characteristics of the donors in 2015 and according to time interval are summarized in 
Table 4. Donor age has been significantly increasing throughout the series, with 55% of donors 
considered suboptimal (age > 45 years) in 2015 (Figure 5). There has been an increase in female 
donors and the percentage of female-to-male transplants (26.4%), as well as cardiac arrest prior to 
donation (21.8% in 2015). In addition, there was an increase in donors who died from stroke, with 
a consequent decrease in deaths from trauma (Figure 6). 
  
Table 4. Donor Characteristics and Ischemia Times in the Spanish Heart Transplantation Registry (1984-2015) 
 
1984-1993 1994-2003 2004-2013 2014-2015 P (trend) 2015 
 
(n = 1230) (n = 3148) (n = 2633) (n = 565) 
 
(n = 299) 
       
Age, y 26.5 ± 10.3 31.3 ± 12.9 36.7 ± 14.4 43.3 ± 14.5 < .001 43.1 ± 14.2 
 Age > 45 y 7.6 19.3 35.6 54.7 < .001 55.5 
Men 78.4 70.9 66.1 59.8 < .001 57.9 
 Female donor-male recipient 17.8 20.9 21.1 24.8 .008 26.4 
Weight, kg 69.4 ± 13.4 70.1 ± 16.1 72.5 ± 17.7 74.4 ± 18.3 < .001 73.8 ± 18.3 
 Recipient/donor weight 1.0 ± 0.2 1. ± 0.3 0.96 ± 0.3 0.97 ± 0.6 < .001 0.94 ± 0.2 
 Recipient/donor weight > 1.20 13.3 15.8 11.1 7.6 < .001 6.0 
 Recipient/donor weight < 0.8 13.8 14.7 19.5 20.2 < .001 19.4 
Cardiac arrest prior to transplanta 3.0 7.2 10.1 19.8 < .001 21.8 
Predonation echocardiographyb 
    
< .001 
 
 Not done 52.5 21.0 5.3 1.1 
 
0.9 
 Normal 47.1 77.7 92.2 96.2 
 
97.0 
 Mild generalized dysfunction 0.3 1.2 2.5 2.7 
 
2.2 
Ischemia time, min 160.8 ± 61.4 184.8 ± 61.7 206.4 ± 63.3 199.2 ± 71.7 < .001 199.0 ± 71.0 
 < 120 min 27.0 18.0 11.2 15.0 < .001 15.0 
 120-180 min 36.2 28.3 22.2 22.7 
 
22.7 
 180-240 min 28.1 36.7 39.0 36.3 
 
37.5 
 > 240 min 8.7 17.1 27.6 26.0 
 
24.8 
       
 
Values expressed are percentages or mean ± standard deviation. 
a Of 4039 transplants. 




Figure 5. Annual changes in donor age and percentages of donors older than 45 years (1984-2015). 95%CI, 95% 




Figure 6. Changes by time period in the causes of death of heart donors. 
Ischemia time has increased throughout the time series. In 2015, as in the previous decade, the 












In 2015, 83.4% of recipients received some type of induction immunosuppressive therapy, 




Figure 8. Drugs used in induction immunosuppression. ALG, antilymphocyte globulin; ATG, antithymocyte globulin. 
The drugs used in the initial immunosuppression and at the end of follow-up for the whole 
series are summarized in Figure 9. In a mean follow-up of 7.2 years, 63.1% of patients continued 
to receive corticoid therapy. At last follow-up, 30% of patients were under treatment with mTor 





Figure 9. Initial and maintenance immunosuppression for the whole series (1984-2015). Progressive changes by type of 
drug: at time of transplant and at end of follow-up. MMF, mycophenolate mofetil; MPS, mycophenolate sodium. 
In 2015, initial immunosuppression predominantly consisted of tacrolimus (89.3%) as the 
calcineurin inhibitor, mycophenolate mofetil or mycophenolic acid (98.3%) as the antiproliferative 
agent, and steroids (98.3%). The annual changes in the use of the various calcineurin inhibitors 
and antimitotics are shown in Figure 10 and Figure 11, respectively. The annual changes in the use 





Figure 10. Annual changes in the use of calcineurin inhibitors (cyclosporine and tacrolimus) in initial immunosuppression 




Figure 11. Annual changes in the use of antimitotics (azathioprine and mycophenolate mofetil/mycophenolic acid) in 




Figure 12. Annual changes in the use of mTor inhibitors (sirolimus and everolimus) in initial immunosuppression in the 




With the most recent update from December 31, 2015, the 1-, 5-, 10-, 15-, and 20-year 
actuarial survivals in the entire time series are summarized in Figure 13. The survival curves 
indicate a mean annual mortality of about 2% to 3% after the first posttransplant year, with a 
median survival of 11.1 years. The 1-year conditional survival is shown in Figure 14. The 
conditional median survival after the first posttransplant year was 15.1 years. There were 
significant differences according to recipient age, donor age, type of procedure (isolated transplant, 
combined transplant, and retransplant), transplanturgency, and type of circulatory assistance at the 
time of transplant (without assistance, balloon pump, extracorporeal membrane oxygenation 
[ECMO], ventricular assist device). The most notable finding was the similar survival between 
elective transplants and transplants performed with balloon pump or ventricular assist devices. 
Transplants performed with prior ECMO showed significantly worse survival than those 








Figure 14. Survival curve conditioned on survival to the first year 
in the whole series (1984-2015). 
  
The survival results have constantly improved throughout the time series (Figure 15). 
Compared with the 1984 to 1993 decade, there were highly significant differences with the second 
decade and the period 2014 to 2015. Compared with the first decade, there was improved survival 
in the first posttransplant year in the following 2 decades. Compared with procedures performed 
between 1993 and 2013, there was an additional improvement in 1-year survival in 2014 and 2015 
(Table 5). The improved survival in the 2004 to 2013 decade vs 1994 to 2014 was observed at a 
longer term (from the second posttransplant year) (Figure 15). The median survival improvement 
is continuous: 9.1 years (1984-1993), 10.9 years (1994-2003), and 12.0 years (2004-2013). In 
addition, the 2014 to 2015 period shows a clear tendency for improved survival vs the previous 
decade (2004-2013), even if this result is not statistically significant due to the relatively small 




Figure 15. Survival curves by transplant period (10-year intervals, 1984-2013 
and 2014-2015). 
  
Table 5. Univariable Survival Analysis by Baseline Characteristics of the Recipient, Donor, and 
Procedure (1984-2015) 
 
HR (95%CI) P 




 < 16 y 1 
 
15.8 (11.6-20.0) 
 16-60 y 1.2 (1.1-1.4) .008 11.7 (11.1-12.2) 
 > 60 y 1.6 (1.3-1.9) < .001 8.6 (7.8-9.4) 
Type of transplant 
 Isolated transplant 1 
 
11.3 (10.0-11.7) 
 Combined transplant 1.3 (1.1-1.6) .01 7.4 (3.9-10.8) 
 Retransplant 1.7 (1.4-2.1) < .001 3.8 (1.1-6.6) 
Donor age 
 ≤ 45 y 1 
 
11.6 (11.1-12.1) 
 > 45 y 1.2 (1.1-1.3) < .001 9.0 (8.0-9.9) 
Procedure urgency 
 Elective 1 
 
11.5 (11.0-12.0) 
 Emergency 1.1 (1.1-1.2) < .001 9.8 (8.6-10.9) 
Type of assistance* 
 Without assistance 1 
 
— 
 Counterpulsation balloon 1.2 (0.9-1.2) .13 — 
 ECMO 1.6 (1.2-2.1) .003 — 
 Ventricular assistance 0.9 (0.7-1.3) .77 — 
    
 
95%CI, 95% confidence interval; ECMO, extracorporeal membrane oxygenation; HR, hazard 
ratio. 
* Patients transplanted between 2009 and 2015. 
Causes of Death 
In the total population, the most frequent cause of death was graft vascular disease/sudden 
death (18.7%), followed by infections (17.1%), primary graft failure (13.6%), and neoplasia 
(13.1%) (Figure 16). The causes of death depended on the time after transplant (Figure 16). In the 
first posttransplant month, almost 50% of deaths were due to primary graft failure. After the first 
month and until 1 year, acute rejection (15.3%) and, above all, infections (36.6%) were the main 
causes of death. After the first year, the main causes were various manifestations of graft vascular 
disease (30.2%) and tumors (22.0%). The main causes of death in the first year have changed 
significantly over time, with fewer deaths due to acute rejection and more deaths due to primary 
graft failure, even if the latter decreased in the 2014 to 2015 period (Figure 17). In deaths 
occurring between the first and fifth posttransplant years, there was a tendency for fewer deaths 






Figure 16. Causes of death by time from transplant and in the whole series (1984-2015). GVD, graft 









Figure 18. Main causes of death occurring between the first year and fifth posttransplant years in the whole series 
(1984-2015). GVD, graft vascular disease; SD, sudden death. 
DISCUSSION 
With the historical perspective provided by more than 30 years of RETC activity, with data on 
practically all heart transplant recipients in Spain, the most important finding of this registry is the 
change in the survival results. After the improved early survival in the second decade of activity 
(1994-2003), which was maintained in the subsequent decade (2004-2013), there has been an 
additional improvement in the last 2 years, with 1-year survival rates close to 80%. In addition, the 
improvement has been constant in the mid- to long-term, and it is hoped that this improvement 
will be maintained, given the tendency of the 2014 to 2015 curve. Both the values and the 
tendencies practically mirror those published by the registry of the International Society for Heart 
and Lung Transplantation for the 1982 to 2013 period
27
. Nonetheless, despite including more than 
100 000 patients from the entire world, this registry has a selection bias, in contrast to the RETC, 
because information is not collected on all patients due to its voluntary nature. 
 
The notable survival improvement in the RETC has been obtained in the context of growing 
recipient, donor, and surgical procedure complexity and has been maintained since about 2009. 
Accordingly, the high percentage of transplants performed under emergency conditions 
(practically half of all procedures) is interesting, as well as the growing use of circulatory assist 
devices. In 2015, less than a quarter of all emergency transplants were performed with a balloon 
pump, a supportive measure that predominated until 2014. The use of ECMO prior to transplant 
has been largely stable since 2013, with a doubling in the use of continuous-flow left ventricular 
assist devices. Although the need for pretransplant circulatory support and the use of ECMO as a 
supportive measure increases early mortality, the prudent use of continuous-flow left ventricular 
assist devices and appropriate care of recipients receiving them is probably responsible for the 
decreased early mortality from primary graft failure. This factor would explain why the short- and 
mid-term survival is statistically similar for elective transplants and transplants performed with the 
prior use of these last devices. 
 
Another interesting observation is that the improved survival in recent periods is not only due 
to improvements in early mortality (in the first year). Conditional survival curves show a 
separation from the second year, a trend that seems to be accentuated for patients transplanted in 
the last 2 years, although a longer clinical course is required to confirm this finding. The cause of 
this observation is undoubtedly multifactorial but there was a notable decrease in mid-term deaths 
due to graft vascular disease in more recent periods. 
CONCLUSIONS 
Heart transplant activity has been stable in Spain in recent years, with about 250 procedures 
per year. Despite the worsening of the current clinical setting and its growing complexity (eg, 
increased use of suboptimal donors and circulatory support), Spanish transplant teams have 
managed to maintain the mortality results and to progressively improve the mid-term prognosis. 
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APPENDIX. COLLABORATORS IN THE SPANISH HEART TRANSPLANTATION REGISTRY 1984-2015 
 
Clínica Universitaria Puerta de Hierro, 
Majadahonda, Madrid 
Manuel Gómez-Bueno, Francisco Hernández-Pérez, Luis Alonso-Pulpón, Alberto 
Forteza-Gil, Santiago Serrano-Fiz, Raúl Burgos-Lázaro, Carlos García-Montero, 
Evaristo Castedo-Mejuto 
Hospital Universitario y Politécnico 
La Fe, Valencia 
Ignacio Sánchez-Lázaro, Luis Martínez-Dolz, Mónica Cebrián-Pinar, Soledad 
Martínez-Penades 
Hospital Universitario de A Coruña, A 
Coruña 
María J. Paniagua-Martin, Eduardo Barge-Caballero, Jose J. Cuenca-Castillo, 
Francisco Estevez-Cid, Gonzalo Barge-Caballero 
Hospital Universitario Reina Sofía, 
Córdoba 
Amador Lopez-Granados, Juan Carlos Castillo-Diéguez 
Hospital Universitario Marqués de 
Valdecilla, Santander 
Manuel Cobo, Miguel Llano-Cardenal, José A. Vázquez de Prada, Francisco 
Nistal-Herrera 
Hospital Gregorio Marañón (adults), 
Madrid 
Paula Navas, Eduardo-Zataraín, Juan Fernández-Yáñez, Adolfo-Villa, Manuel 
Martínez-Sellés 
Hospital Universitario Doce de 
Octubre, Madrid 
Miguel Ángel Gómez-Sánchez, Laura Morán-Fernández 
Hospital de la Santa Creu i Sant Pau, 
Barcelona 
Viçens Brossa, Sònia Mirabet, Laura López 
Hospital Universitario Virgen del 
Rocío, Seville 
Ernesto Lage-Gallé, Diego Rangel-Sousa 
Hospital Universitario de Bellvitge, 
L’Hospitalet de Llobregat, Barcelona 
Nicolás Manito, Josep Roca-Elías, Joel Salazar-Mendiguchía 
Clínica Universitaria de Navarra, 
Pamplona 
Cristian Delgado-Domínguez, Ignacio Bibiloni-Lage 
Hospital Clínic Universitari, Barcelona M. Ángeles Castel, Marta-Farrero, Ana García-Álvarez 
Hospital Universitario Central de 
Asturias, Oviedo 
José Luis Lambert, Beatriz Díez de Molina, María José Bernardo-Rodríguez 
Hospital Universitario Gregorio 
Marañón (pediatric), Madrid 
Manuela Camino, Constancio Medrano 
Hospital Universitario Virgen de la 
Arrixaca, Murcia 
Domingo Pascual-Figal, Iris Garrido-Bravo, Francisco Pastor-Pérez 
Hospital Universitario Miguel Servet, 
Zaragoza 
Teresa Blasco-Peiró, Marisa Sanz-Julvé, Ana Pórtoles-Ocampo 
Hospital Clínico Universitario, 
Valladolid 
Luis de la Fuente-Galán, Javier López-Díaz, Ana María Correa Fernández 
Hospital Universitario La Paz, Madrid Luis García-Guereta, Luz Polo, Carlos Labrandero 
Hospital Universitario Vall d’Hebron, 
Barcelona 
Dimpna C. Albert-Brotons, Ferrán Gran-Ipiña, Raúl Abella 
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